The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)
Open accessAbstract
Objective: To evaluate effects of remote monitoring of adjuvant chemotherapy related side effects via the Advanced Symptom Management System (ASyMS) on symptom burden, quality of life, supportive care needs, anxiety, self-efficacy, and work limitations. Design: Multicentre, repeated measures, parallel group, evaluator masked, stratified randomised controlled trial. Setting: Twelve cancer centres in Austria, Greece, Norway, Republic of Ireland, and UK. Participants: 829 patients with non-metastatic breast cancer, colorectal cancer, Hodgkin’s disease, or non-Hodgkin’s lymphoma receiving first line adjuvant chemotherapy or chemotherapy for the first time in five years. Intervention: Patients were randomised to ASyMS (intervention; n=415) or standard care (control; n=414) over six cycles of chemotherapy. Main outcome measures: The primary outcome was symptom burden (Memorial Symptom Assessment Scale; MSAS). Secondary outcomes were health related quality of life (Functional Assessment of Cancer Therapy—General; FACT-G), Supportive Care Needs Survey Short-Form (SCNS-SF34), State-Trait Anxiety Inventory—Revised (STAI-R), Communication and Attitudinal Self-Efficacy scale for cancer (CASE-Cancer), and work limitations questionnaire (WLQ). Results: For the intervention group, symptom burden remained at pre-chemotherapy treatment levels, whereas controls reported an increase from cycle 1 onwards (least squares absolute mean difference −0.15, 95% confidence interval −0.19 to −0.12; P<0.001; Cohen’s D effect size=0.5). Analysis of MSAS sub-domains indicated significant reductions in favour of ASyMS for global distress index (−0.21, −0.27 to −0.16; P<0.001), psychological symptoms (−0.16, −0.23 to −0.10; P<0.001), and physical symptoms (−0.21, −0.26 to −0.17; P<0.001). FACT-G scores were higher in the intervention group across all cycles (mean difference 4.06, 95% confidence interval 2.65 to 5.46; P<0.001), whereas mean scores for STAI-R trait (−1.15, −1.90 to −0.41; P=0.003) and STAI-R state anxiety (−1.13, −2.06 to −0.20; P=0.02) were lower. CASE-Cancer scores were higher in the intervention group (mean difference 0.81, 0.19 to 1.43; P=0.01), and most SCNS-SF34 domains were lower, including sexuality needs (−1.56, −3.11 to −0.01; P<0.05), patient care and support needs (−1.74, −3.31 to −0.16; P=0.03), and physical and daily living needs (−2.8, −5.0 to −0.6; P=0.01). Other SCNS-SF34 domains and WLQ were not significantly different. Safety of ASyMS was satisfactory. Neutropenic events were higher in the intervention group. Conclusions: Significant reduction in symptom burden supports the use of ASyMS for remote symptom monitoring in cancer care. A “medium” Cohen’s effect size of 0.5 showed a sizable, positive clinical effect of ASyMS on patients’ symptom experiences. Remote monitoring systems will be vital for future services, particularly with blended models of care delivery arising from the covid-19 pandemic. Trial registration: Clinicaltrials.gov NCT02356081 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, several randomized clinical trials with similar interventions have proven that RPM significantly improves symptom burden in comparison with routine care.7,13,14”
From Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium (2024) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
(1970) · Cited by 24,983
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
State-Trait Anxiety Inventory for Adults
Spielberger, C. D. (2012) · PsycTESTS Dataset · doi:10.1037/t06496-000 · Cited by 3,479
Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0830 · Cited by 2,593
Guidance on how to develop complex interventions to improve health and healthcare
O"Cathain, A., Croot, L., Duncan, E., Rousseau, N., Sworn, K., Turner, K. M., Yardley, L., & Hoddinott, P. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029954 · Cited by 1,591
Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Kiyasu, E., Sobel, K., Coyle, N., Kemeny, N. E., Norton, L., et al. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90182-1 · Cited by 1,580
Applications of digital technology in COVID-19 pandemic planning and response
Whitelaw, S., Mamas, M. A., Topol, E., & Van Spall, H. G. C. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30142-4 · Cited by 992
Kotronoulas, G., Kearney, N., Maguire, R., Harrow, A., Domenico, D. D., Croy, S., & MacGillivray, S. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5948 · Cited by 953
Self-citationWang, Y.-H., Li, J.-Q., Shi, J.-F., Que, J.-Y., Liu, J.-J., Lappin, J. M., Leung, J., Ravindran, A. V., Chen, W.-Q., Qiao, Y.-L., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0595-x · Cited by 885
Flagged first, then by citations
1 of the 57 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Di Maio, M., Basch, E., Denis, F., Fallowfield, L. J., Ganz, P. A., Howell, D., Kowalski, C., Perrone, F., Stover, A. M., Sundaresan, P., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.04.007 · Cited by 509
The Lancet Breast Cancer Commission
Coles, C. E., Earl, H. M., Anderson, B. O., Barrios, C. H., Bienz, M., Bliss, J. M., Cameron, D., Cardoso, F., Cui, W., Francis, P. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00747-5 · Cited by 209
Mir, O., Ferrua, M., Fourcade, A., Mathivon, D., Duflot-Boukobza, A., Dumont, S., Baudin, É., Delaloge, S., Malka, D., Albiges, L. K., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01788-1 · Cited by 153
Bonsel, J. M., Itiola, A. J., Huberts, A. S., Bonsel, G. J., & Penton, H. (2024) · Health and Quality of Life Outcomes · doi:10.1186/s12955-024-02312-4 · Cited by 141
Qin, M., Chen, B., Sun, S., & Liu, X. (2022) · Journal of Medical Internet Research · doi:10.2196/39799 · Cited by 69
Metadata
- Authors
- Maguire, R., McCann, L., Kotronoulas, G., Kearney, N., Ream, E., Armes, J., Patiraki, E., Furlong, E., Fox, P., Gaiger, A., McCrone, P., Berg, G., Miaskowski, C., Cardone, A., Orr, D., Flowerday, A., Katsaragakis, S., Darley, A., Lubowitzki, S., Harris, J., Skene, S., Miller, M., Moore, M., Lewis, L., DeSouza, N., & Donnan, P. T.
- Affiliations
- University of Strathclyde (GB)
- University of Glasgow (GB)
- University of Surrey (GB)
- National and Kapodistrian University of Athens (GR)
- University College Dublin (IE)
- Medical University of Vienna (AT)
- King's College London (GB)
- Norwegian University of Science and Technology (NO)
- University of California, San Francisco (US)
- Docobo (United Kingdom) (GB)
- Johnson & Johnson (Germany) (DE)
- University of Dundee (GB)
- Corresponding author
- Maguire, Roma
- ORCID
- Maguire, Roma
- McCann, Lisa
- Kotronoulas, Grigorios
- Kearney, Nora
- Ream, Emma
- Armes, Jo
- Patiraki, Elisabeth
- Furlong, Eileen
- Fox, Patricia
- Gaiger, Alexander
- McCrone, Paul
- Berg, Geir
- Miaskowski, Christine
- Orr, Dawn
- Flowerday, Adrian
- Katsaragakis, Stylianos
- Darley, Andrew
- Lubowitzki, Simone
- Harris, Jenny
- Skene, Simon
- Miller, Morven
- Moore, Margaret
- Lewis, Liane
- Donnan, Peter T
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2021-07-21
- Volume
- 374
- Pages
- n1647
- ISSN
- 1756-1833 (ISSN-L)
- PMC
- PMC8293749
- OpenAlex
- W3183953444
- Cited by
- 243
- References
- 57
- Citations by year
- 2026: 40 · 2025: 58 · 2024: 62 · 2023: 48 · 2022: 31 · 2021: 4
- FWCI
- 13.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BMJ (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (acceptedVersion, cc-by)
- Discovery Research Portal (University of Dundee) (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Funders
- University College London
- European Commission
- Sykehuset Innlandet HF
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- remote symptom monitoring, adjuvant chemotherapy, cancer symptoms, symptom burden, quality of life, supportive care needs, anxiety, self-efficacy, work limitations, non-metastatic breast cancer, colorectal cancer, Hodgkin's disease, non-Hodgkin lymphoma, real-time patient monitoring
- MeSH terms
- Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Austria, Breast Neoplasms, Female, United Kingdom, Greece, Hodgkin Disease, Humans, Ireland, Lymphoma, Non-Hodgkin, Male, Middle Aged, Norway, Quality of Life, Colorectal Neoplasms, Treatment Outcome, Chemotherapy, Adjuvant, Telemedicine, Cell Phone, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
